InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（6 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
6
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Myles David C., Directeur du Développement. Insider active across 1 company, notably Olema Pharmaceuticals, Inc.. Aggregated, 8 disclosures have been logged. Split: 0 buy · 6 sells. Total volume traded: €700k. Activity tracked since 10 December 2021. The latest transaction was filed on 12 January 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Myles David C.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
10,000 股@ US$28.3434.9% 占其流量Common StockSEC:0001831216-26-000003:0
1,225 股@ US$28.086.4% 占其流量Common StockSEC:0001831216-25-000004:0
48,750 股0Common StockSEC:0001415889-24-029027:0
26,250 股0Common StockSEC:0001415889-23-015458:0
200 股@ US$17.610.6% 占其流量Common StockSEC:0001415889-23-015041:0
6,668 股@ US$15.0218.3% 占其流量Common StockSEC:0001415889-23-014792:0
20,000 股@ US$12.6746.1% 占其流量Common StockSEC:0001415889-23-013474:0
10,000 股@ US$10.3013.0% 占其流量Common StockSEC:0001415889-21-005860:0
8 条申报中的 8 条
About Myles David C.
Myles David C. is Directeur du Développement and also holds the role of CH. DISCOV. & NON-CLIN DEV OFF at Olema Pharmaceuticals, Inc. on XNAS. He has 8 filings in total, and across the 8 sampled filings between 2021-12-14 and 2026-01-14, the modal transaction nature is Sell, with total sales of EUR 699536 and no purchases.
